Verdonck L F, de Gast G C, Lange J M, Schuurman H J, Dekker A W, Bast B J
Department of Hematology, University Hospital Utrecht, The Netherlands.
Blood. 1988 Mar;71(3):666-71.
A 22-year-old man who underwent syngeneic bone marrow transplantation (BMT) for acute lymphoblastic leukemia acquired a human immunodeficiency virus (HIV) infection by transfusion of blood products from a donor at risk. The manifestations were acute encephalopathy together with immune thrombocytopenia in the early posttransplant period, and acquired immunodeficiency syndrome (AIDS) developed 20 months after BMT. Because he had a syngeneic donor, the possibility of reconstituting the immune system was investigated by repeated transfer of healthy syngeneic lymphocytes and by combining repeated transfer of syngeneic lymphocytes with the antiviral agent suramin to protect the infused leukocytes from being attacked by HIV. No improvement was observed clinically or in the patient's immune functions by these efforts.
一名22岁的男性因急性淋巴细胞白血病接受了同基因骨髓移植(BMT),通过输注来自有风险供体的血液制品感染了人类免疫缺陷病毒(HIV)。其表现为移植后早期出现急性脑病及免疫性血小板减少,骨髓移植20个月后发展为获得性免疫缺陷综合征(AIDS)。由于他有同基因供体,通过反复输注健康的同基因淋巴细胞以及将同基因淋巴细胞的反复输注与抗病毒药物苏拉明联合使用,以保护输入的白细胞免受HIV攻击,从而研究了重建免疫系统的可能性。通过这些努力,在临床或患者免疫功能方面均未观察到改善。